Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

N.N. Blokhin Russian Cancer Research Center

2 abstracts

Abstract
Four-year outcomes and circulating tumor DNA (ctDNA) analysis of pembrolizumab (pembro) plus concurrent chemoradiation therapy (cCRT) in unresectable, locally advanced, stage III non–small-cell lung cancer (NSCLC): From KEYNOTE-799.
Org: LungenClinic, N.N. Blokhin Russian Cancer Research Center, N.N. Petrov National Medical Research Center of Oncology, Thoracic Oncology Unit, Mid North Coast Cancer Institute,
Abstract
Alternative allele frequency recallibration after NGS data analysis.
Org: OncoAtlas LLC, Atlas Oncodiagnostics, N.N. Blokhin Russian Cancer Research Center,